The Supply@ME Capital share price has risen by 1,000%! Should you buy shares today?

With the Supply@ME Capital share price on a rampage, is now a good time for investors to buy shares in ths up-and-coming company?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

CORRECTION: The original version of this article incorrectly stated that the company’s share price rocketed “from 6p to 80p”. This has been amended to “0.06p to 0.8p”.

Independent fintech company Supply@ME Capital (LSE: SYME) has caught the eye of many investors recently. In just over a week, the company’s share price rocketed 1,233%, from 0.06p to 0.8p.

Such monumental share price gains in a relatively short space of time are rare. That said, when dealing with penny stocks, anything can happen. So, with the Supply@Me Capital share price on the rise again, should investors buy shares today in order to make a tidy profit? Well, I think there are a few things you should know first.

What is Supply@ME Capital?

According to the company’s website, Supply@ME Capital is an “independent fintech company providing an innovative proprietary inventory monetisation service to companies in a wide range of industrial sectors”. As my colleague Edward said in a previous article, “this platform enables businesses to improve their working capital position (generate cash flow) by releasing capital from their inventory”. Essentially, Supply@ME Capital functions by matching the working capital needs of clients with capital invested by inventory funders.

In my view, the business model looks sustainable and I can certainly see the company prospering in the long term. However, there are certainly risks involved. Not to mention the difficulties caused by Covid-19. That said, the group only expects the pandemic to cause a three-to-four-month delay to the business plan.

A surging yet unstable share price

After plunging 23% earlier in the previous week, the Supply@Me Capital share price rose by 21% in early trading yesterday. Such volatility is a regular theme for those familiar with penny stock investing. For example, when the company’s shares were trading at 5p, a 1p increase to 6p was a 20% gain.

On top of this, would-be investors would do well to keep an eye on the sell/buy spread. This is usually quite wide with penny stocks, often requiring a substantial gain in order to simply break even.

What does the future hold

Ultimately, as an early stage fintech company yet to become profitable, investing in Supply@ME Capital is evidently a risky move. That said, if you’re intent on buying, I’d recommend first doing some further research before being prepared to hold for the long term.

It’s encouraging to see to a significant amount of director dealing coming from within the business. This indicates that those on the inside are confident regarding the firm’s long-term outlook. Just last week, the company’s chief executive, Alessandro Zamboni, bought £11m worth of shares valued at 68p each.

It will also be interesting to read over the company’s annual report, which is due to be published in September. By then, we could potentially have a better indication of how to value the company’s stock.

However, I’m not yet fully convinced. Also, I don’t feel as if I know the business well enough to make an investment. Therefore, I’ll certainly be adding Supply@ME Capital to my watchlist, but I’d rather remain on the side-lines for the time being.

Matthew Dumigan has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »